Galapagos Enters November With Flair: New Revelation About Toledo Target Family
GLPG

Galapagos NV (NASDAQ: $GLPG) unveils the Toledo target family as a series of salt-inducible kinase inhibitors. Toledo demonstrates a dual mechanism of action characterized by stimulation of anti-inflammatory cytokines and inhibition of pro-inflammatory cytokines. Galapagos also presented new preclinical data and results in healthy volunteers today. Furthermore, it explains its broad program to discover and…